The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cronin, D. C.
Right arrow Articles by Fitch, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cronin, D. C., 2nd
Right arrow Articles by Fitch, F. W.

The Journal of Immunology, Vol 154, Issue 7 3118-3127, Copyright © 1995 by American Association of Immunologists


ARTICLES

IL-4-producing CD8+ T cell clones can provide B cell help

DC Cronin 2nd, R Stack and FW Fitch
Committee on Immunology, University of Chicago, IL 60637.

Interactions between CD4+ T cells and B cells are mediated by both soluble factors and cell surface molecules. The Ag-independent interaction between the CD40 ligand, expressed on activated T cells, and its CD40 receptor, expressed on B cells, enhances B cell proliferation in response to IL-4 stimulation. The expression of the CD40 ligand is induced on CD4+ T cells by stimulation with Ag-pulsed APC or mitogens. Here, we show that at least some IL-4-producing murine CD8+ T cell clones can be induced to express the CD40 ligand when stimulated with anti-CD3 mAb. Additionally, such activated CD8+ IL-4- producing clones potentiate the proliferative response of small resting B cells to IL-4 and induce Ig secretion by small resting B cells to IL- 4 and IL-5. Proliferation of small resting B cells cultured with IL-4 in the presence of activated IL-4-producing CD8+ murine T cell clones appeared to be mediated by the expression of the CD40 ligand on the T cell because an anti-CD40 ligand mAb inhibited this proliferative response. A conventional murine CD8+ CTL clone, which did not produce IL-4 or express CD40 ligand upon activation, did not potentiate proliferation of small resting B cells exposed to IL-4. Thus, under some circumstances, CD8+ T cells that are able to express CD40 ligand may be able to provide B cell help.


This article has been cited by other articles:


Home page
J. Immunol.Home page
B. J. E. Raveney and D. J. Morgan
Dynamic Control of Self-Specific CD8+ T Cell Responses via a Combination of Signals Mediated by Dendritic Cells
J. Immunol., September 1, 2007; 179(5): 2870 - 2879.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. H. Hernandez, L. Shen, and K. L. Rock
CD40-CD40 Ligand Interaction between Dendritic Cells and CD8+ T Cells Is Needed to Stimulate Maximal T Cell Responses in the Absence of CD4+ T Cell Help
J. Immunol., March 1, 2007; 178(5): 2844 - 2852.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Riou, A. R Dumont, B. Yassine-Diab, E. K Haddad, and R.-P. Sekaly
IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells
Int. Immunol., June 1, 2006; 18(6): 827 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Kienzle, S. Olver, K. Buttigieg, P. Groves, M. L. Janas, A. Baz, and A. Kelso
Progressive Differentiation and Commitment of CD8+ T Cells to a Poorly Cytolytic CD8low Phenotype in the Presence of IL-4
J. Immunol., February 15, 2005; 174(4): 2021 - 2029.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Beacock-Sharp, A. M. Donachie, N. C. Robson, and A. M. Mowat
A role for dendritic cells in the priming of antigen-specific CD4+ and CD8+ T lymphocytes by immune-stimulating complexes in vivo
Int. Immunol., June 1, 2003; 15(6): 711 - 720.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Kienzle, K. Buttigieg, P. Groves, T. Kawula, and A. Kelso
A Clonal Culture System Demonstrates That IL-4 Induces a Subpopulation of Noncytolytic T Cells with Low CD8, Perforin, and Granzyme Expression
J. Immunol., February 15, 2002; 168(4): 1672 - 1681.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Mintern, G. M. Davey, G. T. Belz, F. R. Carbone, and W. R. Heath
Cutting Edge: Precursor Frequency Affects the Helper Dependence of Cytotoxic T Cells
J. Immunol., February 1, 2002; 168(3): 977 - 980.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. A. Green, R. J. Noelle, B. G. Durell, and W. R. Green
Characterization of the CD154-Positive and CD40-Positive Cellular Subsets Required for Pathogenesis in Retrovirus-Induced Murine Immunodeficiency
J. Virol., April 15, 2001; 75(8): 3581 - 3589.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
L. A. Stanciu, K. Roberts, L. C. K. Lau, A. J. Coyle, and S. L. Johnston
Induction of type 2 activity in adult human CD8+ T cells by repeated stimulation and IL-4
Int. Immunol., March 1, 2001; 13(3): 341 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. V. Gorbachev, P. S. Heeger, and R. L. Fairchild
CD4+ and CD8+ T Cell Priming for Contact Hypersensitivity Occurs Independently of CD40-CD154 Interactions
J. Immunol., February 15, 2001; 166(4): 2323 - 2332.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Vizler, N. Bercovici, A. Heurtier, N. Pardigon, K. Goude, K. Bailly, C. Combadiere, and R. S. Liblau
Relative Diabetogenic Properties of Islet-Specific Tc1 and Tc2 Cells in Immunocompetent Hosts
J. Immunol., December 1, 2000; 165(11): 6314 - 6321.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Barnhart, P. A. Kosinski, Z. Wang, G. S. Ford, M. Kiledjian, and L. R. Covey
Identification of a Complex that Binds to the CD154 3' Untranslated Region: Implications for a Role in Message Stability During T Cell Activation
J. Immunol., October 15, 2000; 165(8): 4478 - 4486.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
K. Furukawa, H. Sasaki, R. B. Pollard, and F. Suzuki
Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans
J. Antimicrob. Chemother., September 1, 2000; 46(3): 443 - 450.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Delgado and D. Ganea
Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit T Cell-Mediated Cytotoxicity by Inhibiting Fas Ligand Expression
J. Immunol., July 1, 2000; 165(1): 114 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Sha and R. W. Compans
Induction of CD4+ T-Cell-Independent Immunoglobulin Responses by Inactivated Influenza Virus
J. Virol., June 1, 2000; 74(11): 4999 - 5005.
[Abstract] [Full Text]


Home page
BloodHome page
M. Vukmanovic-Stejic, B. Vyas, P. Gorak-Stolinska, A. Noble, and D. M. Kemeny
Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes
Blood, January 1, 2000; 95(1): 231 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Rodolfo, C. Zilocchi, P. Accornero, B. Cappetti, I. Arioli, and M. P. Colombo
IL-4-Transduced Tumor Cell Vaccine Induces Immunoregulatory Type 2 CD8 T Lymphocytes That Cure Lung Metastases Upon Adoptive Transfer
J. Immunol., August 15, 1999; 163(4): 1923 - 1928.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Erard, J. A. Garcia-Sanz, R. Moriggl, and M.-T. Wild
Presence or Absence of TGF-{beta} Determines IL-4-Induced Generation of Type 1 or Type 2 CD8 T Cell Subsets
J. Immunol., January 1, 1999; 162(1): 209 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. G. Wagner, P. J. Kurtin, A. Wahner, M. Brackertz, D. J. Berry, J. J. Goronzy, and C. M. Weyand
The Role of CD8+ CD40L+ T Cells in the Formation of Germinal Centers in Rheumatoid Synovitis
J. Immunol., December 1, 1998; 161(11): 6390 - 6397.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. R. Thomsen, A. Nansen, J. P. Christensen, S. O. Andreasen, and O. Marker
CD40 Ligand Is Pivotal to Efficient Control of Virus Replication in Mice Infected with Lymphocytic Choriomeningitis Virus
J. Immunol., November 1, 1998; 161(9): 4583 - 4590.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Cerwenka, L. L. Carter, J. B. Reome, S. L. Swain, and R. W. Dutton
In Vivo Persistence of CD8 Polarized T Cell Subsets Producing Type 1 or Type 2 Cytokines
J. Immunol., July 1, 1998; 161(1): 97 - 105.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. A. Nazaruk, R. Rochford, M. V. Hobbs, and M. J. Cannon
Functional Diversity of the CD8+ T-Cell Response to Epstein-Barr Virus (EBV): Implications for the Pathogenesis of EBV-Associated Lymphoproliferative Disorders
Blood, May 15, 1998; 91(10): 3875 - 3883.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.